利记·sbobet(中国)-唯一官方网站

FOSUN DIAGNOSTICS

Founded in 1989, Fosun Diagnostics (Shanghai) Co., Ltd. (Fosun Diagnostics) always upholds the mission of "integrating innovative diagnostic techniques and safeguarding lives and health of the world". Focusing on the IVD industry, it promotes the development and implementation of innovative technologies and products and is committed to becoming a world-leading scientific and technological innovator in the field of comprehensive solutions for medical diagnosis.


On May 18, 2021, "Fosun Long March" was officially renamed "Fosun Diagnostics". It has established six major R&D and production bases in Shanghai, Jiangsu, Hunan, Anhui, Shenzhen and other provinces and cities in China, to continuously improve the integrated industrial layout of "from diagnosis to treatment" for the R&D and manufacturing of in vitro diagnostic instruments and reagents. It has developed a variety of products for clinical chemistry, immunoassays, molecular diagnosis, microbiology and POCT, etc. and has built a large automatic pipeline and a small POCT product group focusing on six major diseases including tumors, digestive and metabolic diseases, cardiovascular and cerebrovascular diseases, reproductive disease, central nervous system diseases and infections.

As of December 31, 2020

  • 763
    medical device registration certificates issued by NMPA
  • 32
    overseas certifications including CE
  • 103
    Valid patents
  • 6 　
    R&D and production bases
  • 1100 　
    employees in China
  • >15%
    of staff engaged in R&D

Six Bases For Fosun Diagnostics

  • Shanghai
    base

    Shanghai base

  • Changsha
    base

    Changsha base

  • Taizhou
    base

    Taizhou base

  • Shengzhen
    base

    Shengzhen base

  • Hefei
    base

    Hefei base

  • Suzhou
    base

    Suzhou base

Solution

  • Biochemical Diagnosis
  • Immune Diagnosis
  • Molecular Diagnosis
  • Microbiological Diagnosis
  • Chronic-care Management
  • Pathological Diagnosis

  • It provides comprehensive routine biochemical indicators related to liver function, renal function, blood lipids and myocardial function, as well as MyCare plasma concentration monitoring products.

  • F-i3000 Automated Chemiluminescence Immunoassay System meets the requirements of clinical tests of samples in large sample sizes and can be equipped with Fosun's customized chemistry XPT analyzer to form a small biochemical immune pipeline.

  • COVID-19 RNA three-target high-sensitivity test reagent is used together with the sampling, RNA extraction and amplification to establish a comprehensive solution for COVID-19, helping the epidemic prevention and control in China and abroad

  • It provides a full-process solution covering microbial identification with mass spectrometry, automatic antimicrobial susceptibility testing and typing of 5 carbapenemases families in CRE.

  • GULP-1 Multifunction Monitoring System is used to monitor 7 indicators such as blood pressure, blood glucose, uric acid and blood lipid to provide users with chronic disease management solutions

  • The main task of pathology is to provide the necessary theoretical basis and practical basis for the diagnosis, treatment and prevention of diseases.